semaglutide shortage 2025 🚨 FDA Ends The FDA has officially declared an end to the shortage of semaglutide, the active ingredient in the popular medications Ozempic and Wegovy. This announcement signals a significant FDA says shortage of Ozempic

As part of a larger crackdown on direct-to-consumer prescription drug advertising, the FDA published over 55 warning letters on September 16 to online sellers of compounded versions of the popular GLP-1 medications for type-2 diabetes and weight loss

If your prescription or instructions reference "units," this may indicate non-FDA-approved compounded products or a potential medication error requiring immediate clarification with your healthcare provider

The oral medication contains semaglutide, the same active ingredient in Wegovy and Ozempic, which is also made by Novo Nordisk and primarily prescribed for type 2 diabetes

The average participant lost about 26 pounds, decreasing from 255 to 229 pounds or approximately 10% of their body weight

Step 2: Eat a high-iron meal